BioCentury
ARTICLE | Clinical News

Tilidine hydrochloride: Phase III completed

February 1, 2010 8:00 AM UTC

China Aoxing completed a double-blind, Chinese Phase III trial evaluating 100 mg Tilidine given once daily for 5 days vs. 10 mg morphine sulfate in 120 patients. ...